We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
SLXN icon
551
Silexion Therapeutics
SLXN
$2.1M
$2.1M $0.1452 2.04%
VIVS icon
552
VivoSim Labs
VIVS
$2.07M
$2.07M $0.1546 1.97%
BRTX icon
553
BioRestorative Therapies
BRTX
$1.93M
$1.93M $1.40 11.4%
PPBT icon
554
Purple Biotech
PPBT
$1.9M
$1.9M $1.17 7.34%
GNPX icon
555
Genprex
GNPX
$1.84M
$1.84M $2.24 9.8%
XRTX icon
556
XORTX Therapeutics
XRTX
$1.82M
$1.82M $1 2.91%
VRAX icon
557
Virax Biolabs
VRAX
$1.63M
$1.63M $1.21 8.33%
GOVX icon
558
GeoVax Labs
GOVX
$1.53M
$1.53M $0.1686 9.31%
CRIS icon
559
Curis
CRIS
$1.46M
$1.46M $0.6000 9.39%
NIKI
560
Niki BioSolutions
NIKI
$1.44M
$1.44M $1.77 9.69%
BBLG icon
561
Bone Biologics
BBLG
$1.29M
$1.29M $0.3804 2.03%
ARTL icon
562
Artelo Biosciences
ARTL
$1.22M
$1.22M $2.22 3.9%
VBIO
563
Valion Bio
VBIO
$1.15M
$1.15M $0.5500 10.8%
MLEC icon
564
Moolec Science
MLEC
$1.02M
$1.02M $1.40 2.19%
BDRX icon
565
Biodexa Pharmaceuticals
BDRX
$945K
$945K $3.43 12.1%
DCOY icon
566
Decoy Therapeutics
DCOY
$701K
$701K $1.07 13%
SCNI
567
Scinai Immunotherapeutics
SCNI
$638K
$638K $0.4716 9.05%
LABT icon
568
Lakewood-Amedex Biotherapeutics
LABT
$474K
$474K $0.2000 15.7%
SPRC icon
569
SciSparc
SPRC
$393K
$393K $0.6763 5.05%
CDT icon
570
CDT Equity Inc
CDT
$52.4K
$52.4K $0.0680 11.7%
19 20 21 22
23

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.31T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $142B, Regeneron Pharmaceuticals (REGN) at $96B and Moderna (MRNA) at $88.5B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.